Page 16 - Seniors Today June2020
P. 16

Medical management of bone health

           ORAL CONTRACEPTIVE
                   PILL (OCP)


           Who might be helped by            The OCP may help extreme athletes, women with current
           taking the OCP                    eating disorders, or those with low oestrogen levels for
                                             other reasons who have either stopped having their
                                             periods, or have periods very infrequently. A lack of
                                             periods is associated with low oestrogen levels, which
                                             reduces bone density.


           How it works                      Using the OCP can restore oestrogen levels to normal, and
                                             research has shown that this may allow bone density to be
                                             better preserved.


           Possible side effects/risks       There is a small increased risk of deep vein thrombosis
                                             (DVT) (blood clots in the veins) with the OCP
                                             Women who smoke should not take the OCP as the risk of
                                             DVT is increased
                                             It is not clear whether the OCP improves bone mass in
                                             those with already lowered bone density



         Hormone replacement therapy (HRT)



          Who might be helped by            HRT can help women at the time of menopause because
          taking HRT                        with menopause there is a dramatic fall in oestrogen levels
                                            and the loss of bone is accelerated.


          How it works                      HRT can lead to higher levels of oestrogen which can
                                            increase bone density.


          Possible side effects/risks       The use of HRT is for menopause symptoms and is
                                            not currently recommended as a first line therapy for
                                            osteoporosis in postmenopausal women


                                            HRT has been linked to a slight increase in risk of breast
                                            cancer after 4-5 years of use in those who take combined
                                            oestrogen and progesterone


                                            The effects of HRT last only whilst you are taking it and as
                                            soon as you stop, the rate of bone loss returns to the rate it
                                            was progressing before you started HRT


    16
   11   12   13   14   15   16   17   18   19   20   21